Profound Medical Corp. (PROF) stock
PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$7.85+0.17 (+2.21%)
Close on Nov 11, 2026Market cap $286.78MP/E –Yield –
Profound Medical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Profound Medical's profit margin for the twelve months ending Sep 30, 2026 was -137.5%. For fiscal 2025 it was -264.4%, against -260.4% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -264.4% | −4.0 |
| FY2024 | Dec 31, 2024 | -260.4% | +133.0 |
| FY2023 | Dec 31, 2023 | -393.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -78.6% | +72.3 |
| Q2 FY2026 | Jun 30, 2026 | -384.2% | +325.6 |
| Q1 FY2026 | Mar 31, 2026 | -132.2% | +277.0 |
| Q4 FY2025 | Dec 31, 2025 | -136.8% | −18.3 |
| Q3 FY2025 | Sep 30, 2025 | -150.8% | +179.9 |
| Q2 FY2025 | Jun 30, 2025 | -709.9% | −400.0 |
| Q1 FY2025 | Mar 31, 2025 | -409.2% | +48.5 |
| Q4 FY2024 | Dec 31, 2024 | -118.5% | – |
| Q3 FY2024 | Sep 30, 2024 | -330.7% | – |
| Q2 FY2024 | Jun 30, 2024 | -309.9% | – |
| Q1 FY2024 | Mar 31, 2024 | -457.6% | – |
See a number that looks wrong?